Takeda Pharmaceutical
TAK
#465
Rank
HK$421.20 B
Marketcap
HK$131.89
Share price
-0.30%
Change (1 day)
13.99%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): HK$2.04 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.73 Billion. In 2025 the company made an earning of HK$26.07 Billion, an increase over its 2024 earnings that were of HK$17.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$2.04 B-92.15%
2025 HK$26.07 B49.03%
2024 HK$17.49 B-2.41%
2023 HK$17.93 B-28.14%
2022 HK$24.95 B-40.9%
2021 HK$42.21 B78.24%
2020 HK$23.68 B246.1%
2019 HK$6.84 B-48.79%
2018 HK$13.36 B-23.64%
2017 HK$17.49 B21.7%
2016 HK$14.37 B-253.01%
2015 -HK$9.4 Billion-159.65%
2014 HK$15.75 B13%
2013 HK$13.94 B2.46%
2012 HK$13.60 B-57.05%
2011 HK$31.67 B-10.49%
2010 HK$35.39 B-3.99%
2009 HK$36.86 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.71 B 9,308.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.77 B 5,616.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$83.04 B 3,735.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.25 B 3,190.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.05 B 2,673.61%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$103.13 B 4,663.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$78.50 B 3,525.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$6.2 Billion-386.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$5.20 B 140.37%๐Ÿ‡ฎ๐Ÿ‡ณ India